Posts tagged ‘cancer’
Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a small number of people, the disease may progress to the lymph nodes or internal organs, causing serious complications.
Here Jasmine Zain, M.D., associate clinical professor and director of City of Hope’s T Cell Lymphoma Program, discusses how in recent years, greater research efforts, advanced treatment options and more collaboration among physicians have contributed to better care and outcomes for patients, and helped many to return to a normal life.
What is cutaneous T cell lymphoma (CTCL) and what are the symptoms?
CTCL is a rare form of lymphoma that arises primarily in the skin. It is not to be confused with the more common forms of skin cancer that include melanoma and squamous cell carcinoma. Lymphomas are cancers of the lymphoid system and usually arise in lymph nodes. However, with skin being the largest lymphoid organ in the body and our first line of defense against the outside environment, occasionally it becomes the site of lymphoma formation. » Continue Reading
Weighing your breast cancer risk? One study suggests a measure to consider is skirt size.
A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk.
The new study, published online in BMJ Open, was based on information from 93,000 women in a British database for cancer screening between 2005 and 2010. All were 50 years old or older, and their average skirt size was a 10. Three out of four women reported gaining sizes. The average size for these women at age 25 was 8, and when they entered the study, the average size was 10.
The study was conducted by researchers at the Gynecological Cancer Research Center at University College London.
Even when considering other risk factors – such as hormone replacement and family history – increased skirt size emerged as the strongest predictor. The skirt size served as a measure of abdominal weight gain. While scientists haven’t pinned down the exact mechanism linking abdominal fat to breast cancer risk, it is known that obesity increases the amount of estrogen in the body. Many breast cancers rely on this hormone to grow. » Continue Reading
Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before.
The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital and laboratory, there is another front for the fight against cancer: The battle for funding to keep this research ongoing.
City of Hope joins the American Association for Cancer Research in support of the Rally for Medical Research on Capitol Hill on Thursday, Sept. 18. Hundreds of organizations and individuals – comprehensive cancer centers, research advocacy groups, clinicians, business leaders, survivors and others – are joining the call to members of Congress to make funding for the National Institutes of Health a priority and stop the chronic decline of public funding for science.
» Continue Reading
Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life.
However, much work remains to be done. On average, one American will die of cancer every minute of every day this year, according to the American Association for Cancer Research, which today released its annual Cancer Progress Report. Following a year that saw six new cancer drugs approved, an estimated 14.5 million cancer survivors living in the United States, and considerable research breakthroughs, now is the time to continue fueling lifesaving cancer research through investment in the National Institutes of Health, National Cancer Institute and other organizations and agencies devoted to cancer research.
While gains in cancer research have been impressive, the pace of progress has been slowed due to years of budget cuts at the NIH and NCI.
“Incredible strides have been made in advancing our understanding, enhancing prevention and improving therapy of cancer,” said Steven Rosen, M.D., provost and chief scientific officer at City of Hope and director of the Comprehensive Cancer Center. “To maintain momentum with the ultimate goal of maximizing cure of these devastating diseases, the necessary funds must be available.”
While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the doctors they want.
Just because health care is more accessible than before, doesn’t necessarily mean it’s less confusing, says Joseph Alvarnas, M.D., director of Medical Quality and Quality, Risk and Regulatory Management at City of Hope.
“You have to realize we’re in un-navigated waters,” Alvarnas said. “We’re here to serve not only as health care providers, but educators. We need to empower people to be active participants in their care.”
There’s more to cancer care than simply helping patients survive. There’s more to cancer treatment than simple survival.
Constant pain should not be part of conquering cancer, insists Betty Ferrell, Ph.D., R.N., director of nursing research and education at City of Hope. She wants patients and caregivers alike to understand, and act on, this principle.
Ferrell, an international expert in palliative care, and her colleagues have spent years investigating pain management and the barriers that prevent patients from receiving the help and medication needed to manage their pain. Overcoming these barriers starts with understanding that pain management is vital. Even when people are fighting cancer, their day-to-day lives should not hampered by physical pain.
“Patients and caregivers need to understand that pain is important,” she said. “Pain has a tremendous impact on quality of life. There is an urgency. If pain is not controlled, their lives are out of control.”
Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts.
The reasons for such a decision vary, according to the breast reconstruction study published Wednesday in JAMA Surgery. More than 48 percent of those who decide against reconstruction say they don’t want to undergo additional surgery, almost 34 percent say reconstruction isn’t important and 36 percent cite a fear of breast implants.
In fact, only about 42 percent of women choose reconstructive surgery after their mastectomy.
Not only is Laura Kruper, M.D., director of the Rita Cooper and J. William Finkel Women’s Health Center, unsurprised by the number of women who forgo reconstruction, she finds the number of patients who do choose surgery encouraging. » Continue Reading
Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother.
This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reunion. Since the program’s inception, City of Hope has performed more than 12,000 hematopoietic cell transplants, for patients ranging in age from less than 1 year old to more than 79 years old.
The reunion of bone marrow transplant patients, one of the highlights of the year for City of Hope, underscores the close relationships that City of Hope caregivers have with their patients, even those who have been free of their cancer for decades. The outcomes for the program underscore the importance of those relationships and the high level of expertise provided here: They are among the very best in the nation. » Continue Reading
An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests.
Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the University of Texas in Austin. The results of the NSAIDS study were published recently in the journal Cancer Research.
A City of Hope expert says the researchers’ conclusion makes sense. Leslie Bernstein, Ph.D., R.N., director of the Division of Etiology at City of Hope, said the study echoes some of the findings of her own research on obesity. » Continue Reading
To be a great cancer hospital, you need a great oncology program. Just ask City of Hope – and Becker’s Hospital Review.
The health care publishing industry stalwart, described as the “leading hospital magazine for hospital business news and analysis for hospital and health system executives,” recently selected City of Hope to its 2014 edition of “100 Hospitals and Health Systems With Great Oncology Programs.”
The inclusion on the list likely comes as no surprise to City of Hope patients and their families, but outside recognition of top quality is always welcome. In offering its list, Becker’s Hospital Review includes this important note: “Organizations cannot pay for inclusion on this list.”
That’s an important distinction, one that isn’t always true for many such lists. » Continue Reading